{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:17:04Z","timestamp":1792876624329,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Beijing Hundred Thousand and Ten Thousand Talent Project","award":["2019A36"],"award-info":[{"award-number":["2019A36"]}]},{"name":"National Key R&D Program of China","award":["2016YFC1301502"],"award-info":[{"award-number":["2016YFC1301502"]}]},{"name":"Beijing Municipal Health Commission","award":["303\u201301\u2013005-0019"],"award-info":[{"award-number":["303\u201301\u2013005-0019"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jns.2020.117020","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T02:06:56Z","timestamp":1594260416000},"page":"117020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Treatment of intracerebral hemorrhage: Current approaches and future directions"],"prefix":"10.1016","volume":"416","author":[{"given":"Wenbo","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jns.2020.117020_bb0005","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","article-title":"Risks of stroke, 1990 and 2016","volume":"379","author":"Global, Regional, and Country-Specific Lifetime","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"van Asch","year":"2010","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1474-4422(12)70104-7","article-title":"Intracerebral haemorrhage: mechanisms of injury and therapeutic targets","volume":"11","author":"Keep","year":"2012","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jns.2020.117020_bb0020","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"issue":"10175","key":"10.1016\/j.jns.2020.117020_bb0025","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","article-title":"Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial","volume":"393","author":"Hanley","year":"2019","journal-title":"Lancet"},{"issue":"9457","key":"10.1016\/j.jns.2020.117020_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(05)70233-6","article-title":"Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial","volume":"365","author":"Mendelow","year":"2005","journal-title":"Lancet"},{"issue":"9890","key":"10.1016\/j.jns.2020.117020_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","article-title":"Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial","volume":"382","author":"Mendelow","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","article-title":"Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial","volume":"18","author":"Selim","year":"2019","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0045","doi-asserted-by":"crossref","DOI":"10.1227\/00006123-199302000-00019","article-title":"Pathophysiology of brain swelling after acute experimental brain compression and decompression","volume":"32","author":"Xu","year":"1993","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrneurol.2014.264","article-title":"Targeting secondary injury in intracerebral haemorrhage--perihaematomal oedema","volume":"11","author":"Urday","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.117020_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(12)70038-8","article-title":"Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study","volume":"11","author":"Demchuk","year":"2012","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jns.2020.117020_bb0060","article-title":"Black hole sign: novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage","volume":"47","author":"Qi","year":"2016","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0065","article-title":"Blend sign on computed tomography: novel and reliable predictor for early hematoma growth in patients with Intracerebral Hemorrhage","volume":"46","author":"Qi","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.117020_bb0070","article-title":"Island sign predicts long-term poor outcome and mortality in patients with intracerebral hemorrhage","volume":"120","author":"Fan","year":"2018","journal-title":"World Neurosurg."},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0075","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2016.1218","article-title":"Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage","volume":"73","author":"Boulouis","year":"2016","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.jns.2020.117020_bb0080","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","article-title":"Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data","volume":"17","author":"Al-Shahi Salman","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.STR.28.1.1","article-title":"Early hemorrhage growth in patients with intracerebral hemorrhage","volume":"28","author":"Brott","year":"1997","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0090","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(11)70264-2","article-title":"Complications of intracerebral haemorrhage","volume":"11","author":"Balami","year":"2012","journal-title":"Lancet Neurol."},{"issue":"10038","key":"10.1016\/j.jns.2020.117020_bb0100","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"10135","key":"10.1016\/j.jns.2020.117020_bb0105","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.jns.2020.117020_bb0110","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.jns.2020.117020_bb0115","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage","volume":"368","author":"Anderson","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.jns.2020.117020_bb0120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral Hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jns.2020.117020_bb0125","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1474-4422(16)30234-4","article-title":"Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial","volume":"15","author":"Hanley","year":"2016","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jns.2020.117020_bb0130","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/STROKEAHA.118.020688","article-title":"Minimally invasive surgery for Intracerebral Hemorrhage","volume":"49","author":"Scaggiante","year":"2018","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2020.117020_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11883-006-0008-x","article-title":"Hemostatic therapy for intracerebral hemorrhage","volume":"8","author":"Rincon","year":"2006","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.jns.2020.117020_bb0140","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jns.2020.117020_bb0150","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ajem.2014.09.023","article-title":"Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis","volume":"32","author":"Zehtabchi","year":"2014","journal-title":"Am. J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2396987316676610","article-title":"Treatment of intracerebral haemorrhage with tranexamic acid - a review of current evidence and ongoing trials","volume":"2","author":"Law","year":"2017","journal-title":"Eur. Stroke J."},{"issue":"10116","key":"10.1016\/j.jns.2020.117020_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","article-title":"Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients","volume":"391","author":"Gayet-Ageron","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/STROKEAHA.119.026128","article-title":"Noncontrast computed tomography signs as predictors of hematoma expansion, clinical outcome, and response to tranexamic acid in acute intracerebral hemorrhage","volume":"51","author":"Law","year":"2020","journal-title":"Stroke"},{"issue":"9678","key":"10.1016\/j.jns.2020.117020_bb0170","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jns.2020.117020_bb0175","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181f735e5","article-title":"Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review","volume":"75","author":"Thompson","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3171\/2009.7.JNS0982","article-title":"Emergency reversal of anticoagulation and antiplatelet therapies in neurosurgical patients","volume":"112","author":"Beshay","year":"2010","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12028-011-9619-3","article-title":"Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage","volume":"16","author":"Naidech","year":"2012","journal-title":"Neurocrit. Care."},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097328","article-title":"Impact of platelet transfusion on survival of patients with intracerebral hemorrhage after administration of anti-platelet agents at a tertiary emergency center","volume":"9","author":"Suzuki","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0195","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/STROKEAHA.114.006061","article-title":"Desmopressin improves platelet activity in acute intracerebral hemorrhage","volume":"45","author":"Naidech","year":"2014","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit. Care."},{"issue":"14","key":"10.1016\/j.jns.2020.117020_bb0205","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of Andexanet Alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for Dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"9\u201310","key":"10.1016\/j.jns.2020.117020_bb0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.18071\/isz.70.0349","article-title":"Administration of idarucizumab in spontaneous intracerebral hemorrhage under dabigatran-therapy","volume":"70","author":"Bereczki","year":"2017","journal-title":"Ideggyogy Sz"},{"issue":"12","key":"10.1016\/j.jns.2020.117020_bb0220","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaneurol.2019.2636","article-title":"Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the SPOTLIGHT and STOP-IT randomized clinical trials","volume":"76","author":"Gladstone","year":"2019","journal-title":"JAMA Neurol."},{"issue":"16","key":"10.1016\/j.jns.2020.117020_bb0225","doi-asserted-by":"crossref","first-page":"320","DOI":"10.21037\/atm.2016.08.04","article-title":"Blood pressure in acute intra-cerebral hemorrhage","volume":"4","author":"Lattanzi","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0230","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/STROKEAHA.109.561795","article-title":"Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT)","volume":"41","author":"Anderson","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0885066604271619","article-title":"A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage","volume":"20","author":"Qureshi","year":"2005","journal-title":"J. Intensive Care Med."},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0240","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneurol.2010.61","article-title":"Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study","volume":"67","author":"Qureshi","year":"2010","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0245","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/STROKEAHA.118.022133","article-title":"Increased blood pressure variability contributes to worse outcome after intracerebral hemorrhage","volume":"49","author":"de Havenon","year":"2018","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/STROKEAHA.117.017701","article-title":"Association between hyperacute stage blood pressure variability and outcome in patients with spontaneous intracerebral hemorrhage","volume":"49","author":"Chung","year":"2018","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jns.2020.117020_bb0255","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0836-4","article-title":"Minimally invasive surgery for intracerebral hemorrhage","volume":"18","author":"Hersh","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"10154","key":"10.1016\/j.jns.2020.117020_bb0260","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(18)31878-6","article-title":"Intracerebral haemorrhage: current approaches to acute management","volume":"392","author":"Cordonnier","year":"2018","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jns.2020.117020_bb0265","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jama.2019.13014","article-title":"Association of surgical hematoma evacuation vs conservative treatment with functional outcome in patients with cerebellar intracerebral hemorrhage","volume":"322","author":"Kuramatsu","year":"2019","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jns.2020.117020_bb0270","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1161\/STROKEAHA.112.666537","article-title":"Decompressive hemicraniectomy in patients with supratentorial intracerebral hemorrhage","volume":"43","author":"Fung","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.117020_bb0275","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clineuro.2014.11.015","article-title":"Decompressive hemicraniectomy with or without clot evacuation for large spontaneous supratentorial intracerebral hemorrhages","volume":"128","author":"Esquenazi","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0280","first-page":"E4","article-title":"Decompressive hemicraniectomy without clot evacuation in dominant-sided intracerebral hemorrhage with ICP crisis","volume":"34","author":"Heuts","year":"2013"},{"issue":"20","key":"10.1016\/j.jns.2020.117020_bb0285","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJM198705143162001","article-title":"Effects of dexamethasone in primary supratentorial intracerebral hemorrhage","volume":"316","author":"Poungvarin","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jns.2020.117020_bb0290","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamaneurol.2014.1065","article-title":"Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study","volume":"71","author":"Fu","year":"2014","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.jns.2020.117020_bb0295","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/STROKEAHA.117.018658","article-title":"Minocycline in acute cerebral hemorrhage: an early phase randomized trial","volume":"48","author":"Fouda","year":"2017","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0300","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/STROKEAHA.106.472746","article-title":"Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT trial","volume":"38","author":"Lyden","year":"2007","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2020.117020_bb0305","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ene.12140","article-title":"Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: a multicenter randomized controlled trial","volume":"20","author":"Lee","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2020.117020_bb0310","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.STR.23.7.967","article-title":"Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial","volume":"23","author":"Yu","year":"1992","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jns.2020.117020_bb0315","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.WCB.0000073905.87928.6D","article-title":"Heme and Iron metabolism: role in cerebral hemorrhage","volume":"23","author":"Wagner","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0320","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1747-4949.2011.00761.x","article-title":"Design of a prospective, dose-escalation study evaluating the safety of pioglitazone for hematoma resolution in intracerebral hemorrhage (SHRINC)","volume":"8","author":"Gonzales","year":"2013","journal-title":"Int. J. Stroke"},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0325","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/ijs.12220","article-title":"Targeted temperature management after intracerebral hemorrhage (TTM-ICH): methodology of a prospective randomized clinical trial","volume":"9","author":"Rincon","year":"2014","journal-title":"Int. J. Stroke"},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0330","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1747-4949.2011.00707.x","article-title":"Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial","volume":"7","author":"Kollmar","year":"2012","journal-title":"Int. J. Stroke"},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0335","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0028-1082064","article-title":"Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study","volume":"70","author":"Tapia-Perez","year":"2009","journal-title":"Cent. Eur. Neurosurg."},{"key":"10.1016\/j.jns.2020.117020_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pneurobio.2013.11.003","article-title":"Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation","volume":"115","author":"Zhou","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.jns.2020.117020_bb0345","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.STR.4.4.541","article-title":"Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage","volume":"4","author":"Tellez","year":"1973","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.jns.2020.117020_bb0350","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1161\/STROKEAHA.111.618215","article-title":"Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke","volume":"42","author":"Switzer","year":"2011","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2020.117020_bb0355","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12975-012-0150-4","article-title":"Minocycline prevents IL-6 increase after acute ischemic stroke","volume":"3","author":"Switzer","year":"2012","journal-title":"Transl. Stroke Res."},{"issue":"4","key":"10.1016\/j.jns.2020.117020_bb0360","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0271678X17753590","article-title":"Hematoma clearance as a therapeutic target in intracerebral hemorrhage: from macro to micro","volume":"38","author":"Wilkinson","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"6662","key":"10.1016\/j.jns.2020.117020_bb0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jns.2020.117020_bb0370","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.21097","article-title":"Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia\/macrophages","volume":"61","author":"Zhao","year":"2007","journal-title":"Ann. Neurol."},{"issue":"3 Suppl","key":"10.1016\/j.jns.2020.117020_bb0375","first-page":"S92","article-title":"Hematoma resolution as a therapeutic target: the role of microglia\/macrophages","volume":"40","author":"Zhao","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2020.117020_bb0380","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.21097","article-title":"Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia\/macrophages","volume":"61","author":"Zhao","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1 Suppl 1","key":"10.1016\/j.jns.2020.117020_bb0385","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12975-012-0171-z","article-title":"Ischemic preconditioning attenuates brain edema after experimental intracerebral hemorrhage","volume":"3","author":"He","year":"2012","journal-title":"Transl. Stroke Res."},{"issue":"2","key":"10.1016\/j.jns.2020.117020_bb0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1179\/1743132811Y.0000000073","article-title":"Effect of remote ischemic postconditioning on an intracerebral hemorrhage stroke model in rats","volume":"34","author":"Geng","year":"2012","journal-title":"Neurol. Res."},{"issue":"10","key":"10.1016\/j.jns.2020.117020_bb0395","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1084\/jem.20171905","article-title":"Remote ischemic post-conditioning promotes hematoma resolution via AMPK-dependent immune regulation","volume":"215","author":"Vaibhav","year":"2018","journal-title":"J. Exp. Med."},{"issue":"10 Suppl","key":"10.1016\/j.jns.2020.117020_bb0400","first-page":"S99","article-title":"Neuroprotective strategies for intracerebral hemorrhage: trials and translation","volume":"41","author":"Kellner","year":"2010","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.jns.2020.117020_bb0405","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/neurintsurg-2017-013197","article-title":"Neuroprotective strategies following intraparenchymal hemorrhage","volume":"9","author":"Babadjouni","year":"2017","journal-title":"J. Neurointerv. Surg."},{"issue":"12","key":"10.1016\/j.jns.2020.117020_bb0410","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1161\/STROKEAHA.117.017283","article-title":"Reconsidering Neuroprotection in the reperfusion era","volume":"48","author":"Savitz","year":"2017","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jns.2020.117020_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/bc.bc_58_19","article-title":"Multiphase adjuvant neuroprotection: a novel paradigm for improving acute ischemic stroke outcomes","volume":"6","author":"Zhao","year":"2020","journal-title":"Brain Circ."},{"key":"10.1016\/j.jns.2020.117020_bb0420","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-015-0287-3","article-title":"Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits","volume":"15","author":"Wu","year":"2015","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.jns.2020.117020_bb0425","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10571-015-0245-z","article-title":"Enhanced neuroprotection of minimally invasive surgery joint local cooling lavage against ICH-induced inflammation injury and apoptosis in rats","volume":"36","author":"Liu","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.jns.2020.117020_bb0430","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1177\/0271678X18798162","article-title":"A new era for stroke therapy: integrating neurovascular protection with optimal reperfusion","volume":"38","author":"Shi","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.jns.2020.117020_bb0435","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O\u2019Collins","year":"2006","journal-title":"Ann. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20303579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:54:03Z","timestamp":1758383643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20303579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":87,"alternative-id":["S0022510X20303579"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117020","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of intracerebral hemorrhage: Current approaches and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117020"}}